Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Bluesail Boyuan Medical Technology develops and manufactures innovative interventional medical devices, including shock-wave balloon catheters and coronary balloon dilation catheters. Its "Heart Qi" coronary balloon has received regulatory approval in China, while its intravascular lithotripsy device is under clinical investigation for treating calcified carotid lesions[7][8][9].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Bluesail Boyuan Medical Technology.